Nick’s legal practice combines extensive experience in strategic intellectual property (“IP”) portfolio development and IP litigation with an expertise in business development (drug development, product acquisition and life-cycle management) and negotiating commercial contracts (licensing, manufacturing, development, supply, distribution and marketing agreements) for clients in the areas of pharmaceuticals and other health sciences.
Nick regularly advises clients in building their IP portfolios from the ground up, along with providing IP enforcement and defense strategies around new product portfolios and clinical strategies relating to chemical, pharmaceutical, biotech and natural health products.
Prior to being called to the bar, Nick conducted research in cancer treatments and worked within the regulatory and quality control areas of the pharmaceutical industry. Nick has also served as Director and Treasurer of the Canadian Association of Professional Regulatory Affairs. As a result of this work, Nick regularly advises clients in drug regulatory and data protection matters in Canada.
Nick has been able to leverage his experience in the pharmaceutical industry to provide cost-effective advice to both large public and small privately held clients. Working with these clients has provided him with an understanding of the cost pressures of today’s health sciences industry and the need to provide efficient and creative solutions to navigate through the changing nature of the patent and regulatory regime in Canada.